Brief: Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
15/05/2024 12:05
May 15 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® ANNOUNCES PRELIMINARY COLLABORATION
WITH
GCAR FOR INCLUSION OF PELAREOREP IN ANTICIPATED PANCREATIC
CANCER TRIAL
* ONCOLYTICS BIOTECH INC - GCAR LAUNCHES NEW PROTOCOL FOR
PANCREATIC CANCER
Source text for Eikon: ID:nPreMrQ4ra
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer